These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1652952)

  • 1. [Ala1,3,11,15]endothelin-1 analogs with ETB agonistic activity.
    Saeki T; Ihara M; Fukuroda T; Yamagiwa M; Yano M
    Biochem Biophys Res Commun; 1991 Aug; 179(1):286-92. PubMed ID: 1652952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different distribution of endothelin receptor subtypes in pulmonary tissues revealed by the novel selective ligands BQ-123 and [Ala1,3,11,15]ET-1.
    Nakamichi K; Ihara M; Kobayashi M; Saeki T; Ishikawa K; Yano M
    Biochem Biophys Res Commun; 1992 Jan; 182(1):144-50. PubMed ID: 1310013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship for ETB agonism in truncated endothelin-1 analogs.
    Saeki T; Ihara M; Fukuroda T; Yano M
    Biochem Int; 1992 Oct; 28(2):305-12. PubMed ID: 1456952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel radioligand [125I]BQ-3020 selective for endothelin (ETB) receptors.
    Ihara M; Saeki T; Fukuroda T; Kimura S; Ozaki S; Patel AC; Yano M
    Life Sci; 1992; 51(6):PL47-52. PubMed ID: 1321937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor.
    Ihara M; Ishikawa K; Fukuroda T; Saeki T; Funabashi K; Fukami T; Suda H; Yano M
    J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S11-4. PubMed ID: 1282942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor.
    Ihara M; Noguchi K; Saeki T; Fukuroda T; Tsuchida S; Kimura S; Fukami T; Ishikawa K; Nishikibe M; Yano M
    Life Sci; 1992; 50(4):247-55. PubMed ID: 1310132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptor.
    Takai M; Umemura I; Yamasaki K; Watakabe T; Fujitani Y; Oda K; Urade Y; Inui T; Yamamura T; Okada T
    Biochem Biophys Res Commun; 1992 Apr; 184(2):953-9. PubMed ID: 1315540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
    Warner TD; Allcock GH; Corder R; Vane JR
    Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle.
    Davenport AP; O'Reilly G; Molenaar P; Maguire JJ; Kuc RE; Sharkey A; Bacon CR; Ferro A
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S22-5. PubMed ID: 7509950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An endothelin receptor (ETA) antagonist isolated from Streptomyces misakiensis.
    Ihara M; Fukuroda T; Saeki T; Nishikibe M; Kojiri K; Suda H; Yano M
    Biochem Biophys Res Commun; 1991 Jul; 178(1):132-7. PubMed ID: 1648907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin receptors in human coronary artery and aorta.
    Bacon CR; Davenport AP
    Br J Pharmacol; 1996 Mar; 117(5):986-92. PubMed ID: 8851522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid peptides constructed from RES-701-1, an endothelin B receptor antagonist, and endothelin; binding selectivity for endothelin receptors and their pharmacological activity.
    Shibata K; Suzawa T; Ohno T; Yamada K; Tanaka T; Tsukuda E; Matsuda Y; Yamasaki M
    Bioorg Med Chem; 1998 Dec; 6(12):2459-67. PubMed ID: 9925302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ETA and ETB receptors coexist on rabbit pulmonary artery vascular smooth muscle mediating contraction.
    LaDouceur DM; Flynn MA; Keiser JA; Reynolds E; Haleen SJ
    Biochem Biophys Res Commun; 1993 Oct; 196(1):209-15. PubMed ID: 8216294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-1 analogues substituted at both position 18 and 19: highly potent endothelin antagonists with no selectivity for either receptor subtype ETA or ETB.
    Kikuchi T; Kubo K; Ohtaki T; Suzuki N; Asami T; Shimamoto N; Wakimasu M; Fujino M
    J Med Chem; 1993 Dec; 36(25):4087-93. PubMed ID: 8258832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of [125I]-endothelin-1 and [125I]-BQ3020 binding to rat cerebellar endothelin receptors.
    Widdowson PS; Kirk CN
    Br J Pharmacol; 1996 Aug; 118(8):2126-30. PubMed ID: 8864551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of cyclic pentapeptide endothelin A receptor antagonists.
    Fukami T; Nagase T; Fujita K; Hayama T; Niiyama K; Mase T; Nakajima S; Fukuroda T; Saeki T; Nishikibe M
    J Med Chem; 1995 Oct; 38(21):4309-24. PubMed ID: 7473559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin receptor subtypes in human and guinea-pig pulmonary tissues.
    Hay DW; Luttmann MA; Hubbard WC; Undem BJ
    Br J Pharmacol; 1993 Nov; 110(3):1175-83. PubMed ID: 8298806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.
    Hay DW; Luttmann MA; Beck G; Ohlstein EH
    Br J Pharmacol; 1996 Jul; 118(5):1209-17. PubMed ID: 8818345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonists.
    Cody WL; He JX; DePue PL; Waite LA; Leonard DM; Sefler AM; Kaltenbronn JS; Haleen SJ; Walker DM; Flynn MA
    J Med Chem; 1995 Jul; 38(15):2809-19. PubMed ID: 7636842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin and endothelin antagonists: pharmacology and clinical implications.
    Lüscher TF; Wenzel RR
    Agents Actions Suppl; 1995; 45():237-53. PubMed ID: 7717186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.